HOME › DRUGS › OCRELIZUMAB AND HYALURONIDASE-OCSQ
ACTIVE SUBSTANCE / INN

OCRELIZUMAB AND HYALURONIDASE-OCSQ

Brand name(s): OCREVUS ZUNOVO
FDA LISTED
PRESCRIPTION
BLA761371
ACTIVE SUBSTANCE
Ocrelizumab And Hyaluronidase-Ocsq
REGULATORS
FDA
SPONSORS / MAH
GENENTECH INC
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
OCREVUS ZUNOVOBLA761371GENENTECH INCPrescription

FULL INTELLIGENCE ON OCRELIZUMAB AND HYALURONIDASE-OCSQ

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →